GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Anchor Capital Advisors LLC

Anchor Capital Advisors LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 56.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 441,744 shares of the company's stock after buying an additional 159,851 shares during the quarter. Anchor Capital Advisors LLC owned 0.10% of GE HealthCare Technologies worth $34,536,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in GEHC. LGT Financial Advisors LLC raised its position in GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after acquiring an additional 251 shares during the period. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $26,000. Ashton Thomas Securities LLC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $26,000. Darwin Wealth Management LLC purchased a new stake in GE HealthCare Technologies during the 3rd quarter worth approximately $31,000. Finally, Continuum Advisory LLC lifted its position in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after acquiring an additional 168 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 2.6 %

GE HealthCare Technologies stock traded down $2.21 during mid-day trading on Tuesday, hitting $84.24. The company had a trading volume of 2,678,454 shares, compared to its average volume of 2,892,884. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The business has a fifty day moving average of $86.31 and a 200 day moving average of $86.14. The stock has a market cap of $38.52 billion, a price-to-earnings ratio of 19.41, a PEG ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80.

Remove Ads

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently commented on GEHC. Citigroup increased their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research note on Thursday, February 13th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and increased their price objective for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company boosted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.